1
Clinical Trials associated with Propylene glycol/Polyethylene glycol 400/GlycerinPhase I Clinical Study to Evaluate the Safety and Tolerability of PRO-240 Ophthalmic Solution Compared to Optive® on the Ocular Surface of Ophthalmologically and Clinically Healthy Volunteers
This is a phase I clinical study to evaluating safety and tolerability of PRO-240 ophthalmic solution through the incidence of unexpected adverse events, as well as through changes in Best Corrected Visual Acuity (BCVA), and the incidence of stinging after its administration, compared to Optive®.
100 Clinical Results associated with Propylene glycol/Polyethylene glycol 400/Glycerin
100 Translational Medicine associated with Propylene glycol/Polyethylene glycol 400/Glycerin
100 Patents (Medical) associated with Propylene glycol/Polyethylene glycol 400/Glycerin
100 Deals associated with Propylene glycol/Polyethylene glycol 400/Glycerin